BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21755501)

  • 1. Killer cell immunoglobulin-like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a.
    Vejbaesya S; Nonnoi Y; Tanwandee T; Srinak D
    J Med Virol; 2011 Oct; 83(10):1733-7. PubMed ID: 21755501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.
    Marangon AV; Silva GF; de Moraes CF; Grotto RM; Pardini MI; de Pauli DS; Sell AM; Visentainer JE; Moliterno RA
    Hum Immunol; 2011 Nov; 72(11):1074-8. PubMed ID: 21920398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-C and KIR genes in hepatitis C virus infection.
    Montes-Cano MA; Caro-Oleas JL; Romero-Gómez M; Diago M; Andrade R; Carmona I; Aguilar Reina J; Núñez-Roldán A; González-Escribano MF
    Hum Immunol; 2005 Nov; 66(11):1106-9. PubMed ID: 16571411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell receptor and HLA-C gene polymorphisms among patients with hepatitis C: a comparison between sustained virological responders and non-responders.
    Carneiro VL; Lemaire DC; Bendicho MT; Souza SL; Cavalcante LN; Angelo AL; Freire SM; Mendes CM; Santana N; Lyra LG; Lyra AC
    Liver Int; 2010 Apr; 30(4):567-73. PubMed ID: 20456039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.
    Vidal-Castiñeira JR; López-Vázquez A; Díaz-Peña R; Alonso-Arias R; Martínez-Borra J; Pérez R; Fernández-Suárez J; Melón S; Prieto J; Rodrigo L; López-Larrea C
    J Virol; 2010 Jan; 84(1):475-81. PubMed ID: 19846535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
    Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
    Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-C C1C2 heterozygosity may protect women bearing the killer immunoglobulin-like receptor AA genotype from spontaneous abortion.
    Nowak I; Malinowski A; Tchórzewski H; Barcz E; Wilczyński JR; Banasik M; Gryboś M; Kurpisz M; Luszczek W; Majorczyk E; Wiśniewski A; Senitzer D; Sun JY; Kuśnierczyk P
    J Reprod Immunol; 2011 Jan; 88(1):32-7. PubMed ID: 21134695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia.
    Kuśnierczyk P; Mozer-Lisewska I; Zwolińska K; Kowala-Piaskowska AE; Bura M; Bereszyńska I; Pauli A; Żeromski J
    Hum Immunol; 2015 Mar; 76(2-3):102-8. PubMed ID: 25636579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection.
    Rauch A; Laird R; McKinnon E; Telenti A; Furrer H; Weber R; Smillie D; Gaudieri S;
    Tissue Antigens; 2007 Apr; 69 Suppl 1():237-40. PubMed ID: 17445209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C.
    Romero-Gómez M; González-Escribano MF; Torres B; Barroso N; Montes-Cano MA; Sánchez-Muñoz D; Núñez-Roldan A; Aguilar-Reina J
    Am J Gastroenterol; 2003 Jul; 98(7):1621-6. PubMed ID: 12873589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
    De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA and killer immunoglobulin-like receptor genes as outcome predictors of hepatitis C virus-related hepatocellular carcinoma.
    Cariani E; Pilli M; Zerbini A; Rota C; Olivani A; Zanelli P; Zanetti A; Trenti T; Ferrari C; Missale G
    Clin Cancer Res; 2013 Oct; 19(19):5465-73. PubMed ID: 23938290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of killer cell immunoglobulin-like receptors with spontaneous clearance of hepatitis C virus in the Chinese population.
    Shan Z; Huang J; Liao Q; Huang K; Wang M; Xu R; Tang X; Zhang W; Nelson K; Fu Y; Li C; Rong X
    Transfusion; 2018 Apr; 58(4):1028-1035. PubMed ID: 29446443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-C/KIR genotypes in oral lichen planus patients infected or non-infected with hepatitis C virus.
    Carrozzo M; Elia A; Mereu V; Dametto E; Fasano M; Broccoletti R; Rendine S; Amoroso A
    Oral Dis; 2011 Apr; 17(3):309-13. PubMed ID: 20860769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of KIR genes in HLA-identical sibling hematopoietic stem cell transplantation in Thai patients with leukemia.
    Wongwuttisaroj N; Vejbaesya S; Chongkolwatana V; Issaragrisil S
    J Med Assoc Thai; 2012 Oct; 95(10):1261-5. PubMed ID: 23193738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
    Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
    Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.
    Jobim M; Chagastelles P; Salim PH; Portela P; Wilson TJ; Curti AG; Jobim MR; João DA; Nardi NB; Tschiedel B; Jobim LF; Roesler R; Schwartsmann G
    Hum Immunol; 2010 Aug; 71(8):799-803. PubMed ID: 20580654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
    Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patients.
    Ursu LD; Calenic B; Diculescu M; Dima A; Stoian IT; Constantinescu I
    Int J Immunogenet; 2021 Feb; 48(1):16-24. PubMed ID: 32961633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.